Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
WDR72 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
BMPR2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MED8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ANKFY1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CANX - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
HIST1H2AH - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
SLC33A1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HIPK1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100506314 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GPD2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TFG - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RPEL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ACSL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TRIM69 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LIMD2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GPR107 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MFSD9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ADAM9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on